NCT01451632 2016-09-08A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced CancersMerrimack PharmaceuticalsPhase 1 Completed48 enrolled 14 charts
NCT01151046 2016-05-12Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast CancerMerrimack PharmaceuticalsPhase 2 Completed118 enrolled 13 charts
NCT01421472 2016-05-03A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerMerrimack PharmaceuticalsPhase 2 Completed196 enrolled 12 charts